Skip to main content
Caplight Logo









Breath Diagnostics

Breath Diagnostics

Private
Louisville, KentuckyHealthcare & Life Scienceshttps://breathdiagnostics.com/

Last Round

Crowdfunding

May 5, 2025

Est. Valuation

$32.1M

Total Funding Raised

$1M

Company Overview

Breath Diagnostics is a medical technology company that develops a non-invasive diagnostic platform for early disease detection by analyzing exhaled breath.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

breath analysisnon-invasive diagnosticslung cancer screeningdisease breathalyzerVOC analysisAI diagnosticsin-vitro diagnosticIVDbiomarker discoveryLC-MSlaboratory-developed testLDTpneumonia detectionmedtechmicroreactor technologyFDA Breakthrough Device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Breath Diagnostics Comparables

Compare Breath Diagnostics with similar companies based on industry and business-model similarity.

Breath Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vocxi Health
86%
BreathDX
83%
Breathomix
79%

Breath Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingMay 5, 2025
Convertible DebtOct 31, 2024

Breath Diagnostics Investors

Notable investors and investment history

Breath Diagnostics investors
InvestorRounds
National Cancer InstituteGrant
The Wallace H. Coulter FoundationGrant
Gates FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 35% to 1,012.

  • Dec 8, 2025

    Monthly visitors increased 83% MoM.

Breath Diagnostics Filings

Explore SEC and related filing metadata, where available.

Breath Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Breath Diagnostics's valuation, stock price, and market status.

Is Breath Diagnostics a public or private company?

Breath Diagnostics is a private company.

What is the current stock price of Breath Diagnostics?

Breath Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is Breath Diagnostics worth (valuation)?

Breath Diagnostics's valuation is estimated at $32.1M based on funding round data.

Can I buy Breath Diagnostics stock?

Breath Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Breath Diagnostics's last funding round?

Breath Diagnostics's most recent funding round was Crowdfunding on May 5, 2025.

Who are the main investors in Breath Diagnostics?

Key investors in Breath Diagnostics include National Cancer Institute, Wallace H. Coulter Foundation, Gates Foundation.

Will Breath Diagnostics IPO soon?

No public IPO plans have been announced for Breath Diagnostics.

How can I track Breath Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Breath Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLouisville, Kentucky
Employee Range6
Year Founded2015
Last FundingMay 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?